THING ON ENT (02292) announced its interim results for 2025, reporting revenue of HK$17.185 million, a decrease of 7.44% compared to the same period last year. The company recorded a net loss of HK$23.271 million, representing a 57.86% narrowing year-on-year. Loss per share was HK$0.0323. According to the announcement, the loss was primarily attributable to fair value losses on investment properties of approximately HK$31.3 million during the period (2024: HK$65.3 million).